Eleckta Limited
United KingdomFDA applicant, unverified
- Devices
- 1
What Eleckta Limited makes
Eleckta Limited manufactures radiation therapy systems, including the Precise Treatment System and its variants: Synergy platform, Synergy, Infinity, and VersaHD. These devices are designed for external beam radiotherapy, delivering precise radiation doses to treat cancerous tumors with advanced imaging and treatment planning capabilities.
The company’s portfolio is regulated under Class II medical devices in the US, with devices listed via the FDA’s 510(k) pathway. The manufacturer is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Eleckta Limited have in the registry?
The registry currently lists 1 device for Eleckta Limited. Devices recorded under merged duplicate company entries are counted once.
Which registries list Eleckta Limited's devices?
Among its 1 most recently registered device, Eleckta Limited has devices listed in FDA 510(k) (1 device).
What risk classes do Eleckta Limited's devices fall under?
Among its 1 most recently registered device, the classes recorded for Eleckta Limited's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Eleckta Limited in the registry?
The most recently registered devices listed for Eleckta Limited include Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD.